Dabigatran etexilate capsules (Pradaxa) belong to which class of medicine?

Dabigatran etexilate (Pradaxa) is an oral anticoagulant drug that belongs to the specific category of direct thrombin inhibitors. The main function of this class of drugs is to interfere with the blood coagulation process by directly inhibiting the activity of thrombin, thereby preventing or treating thrombosis-related diseases. Thrombin is an enzyme that is crucial in the blood coagulation process and can catalyze the conversion of fibrinogen into fibrin, leading to blood coagulation.

Direct thrombin inhibitors are different from traditional anticoagulants. Traditional anticoagulant drugs such as warfarin (warfarin) affect the synthesis of coagulation factors by affecting the metabolism of vitamin K, while direct thrombin inhibitors directly act on key steps of the coagulation cascade and have a more direct and specific anticoagulant effect.

Dabigatran etexilate capsules, as a representative of direct thrombin inhibitors, have multiple advantages. First of all, it is an oral drug, which is more convenient than traditional injectable anticoagulants, improving patient convenience. Secondly, the effect of dabigatran etexilate is reversible, which means that its anticoagulant effect can be quickly reversed by administering a reversal agent if necessary, increasing management flexibility in emergency situations.

Overall, dabigatran etexilate capsules, as direct thrombin inhibitors, provide an advanced and effective option for anticoagulation therapy. However, patients should receive a comprehensive evaluation before use and use the medication rationally under the guidance of a doctor to ensure the best therapeutic effect and minimize potential risks.

Dabigatran etexilate capsules have been launched in China and have been included in medical insurance. Patients can purchase them domestically. Please consult the local hospital pharmacy for specific prices. The main foreign drug is the original drug of dabigatran etexilate capsules. The cheaper one is the Turkish version of the original drug from Germany. The price of 110mg*60 capsules is about three to four hundred, and the ingredients and efficacy are consistent with the original drug on the domestic market.